Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)

Saved in:
Bibliographic Details
Published in:European heart journal 2021-10, Vol.42 (Supplement_1)
Main Authors: Eliaz, R, Mengesha, B, Ovdat, T, Iakobishvili, Z, Hasdai, D, Kheifets, M, Klempfner, R, Beigel, R, Kalmanovich, E, Alcalai, R, Levi, A
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue Supplement_1
container_start_page
container_title European heart journal
container_volume 42
creator Eliaz, R
Mengesha, B
Ovdat, T
Iakobishvili, Z
Hasdai, D
Kheifets, M
Klempfner, R
Beigel, R
Kalmanovich, E
Alcalai, R
Levi, A
description
doi_str_mv 10.1093/eurheartj/ehab724.1414
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehab724_1414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_eurheartj_ehab724_1414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1374-2fea3c5fbddc274917cd38c7a75d4acb989597b6b2b264e126803891340c88e93</originalsourceid><addsrcrecordid>eNp1kMtKAzEYhYMoWKuvIFnWxbS5TSZZlsFLoWCxCroaksw_nZR2piQzhT6Gb2yLxZ2rsziHj8OH0D0lY0o0n0AfajChW0-gNjZjYkwFFRdoQFPGEi1FeokGhOo0kVJ9XqObGNeEECWpHKDvN9hDiN5uAC_YF2XYN7W3vmsDPhV9xD6E_ze-wdN8iXem89B0EfdNCWHV-maFF_kMj7oasHF9B9i1oW1MOOB4aMrQbgH7GAxsPI592MMBj46g2fLhFl1VZhPh7pxD9PH0-J6_JPPX51k-nSeO8kwkrALDXVrZsnQsE5pmruTKZSZLS2Gc1UqnOrPSMsukAMqkIlxpygVxSoHmQyR_uS60MQaoil3w2-PBgpLiJLb4E1ucxRYnsfwH-GZx6w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)</title><source>Oxford Journals Online</source><creator>Eliaz, R ; Mengesha, B ; Ovdat, T ; Iakobishvili, Z ; Hasdai, D ; Kheifets, M ; Klempfner, R ; Beigel, R ; Kalmanovich, E ; Alcalai, R ; Levi, A</creator><creatorcontrib>Eliaz, R ; Mengesha, B ; Ovdat, T ; Iakobishvili, Z ; Hasdai, D ; Kheifets, M ; Klempfner, R ; Beigel, R ; Kalmanovich, E ; Alcalai, R ; Levi, A ; Acute Coronary Syndrome Israeli Survey (ACSIS)</creatorcontrib><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehab724.1414</identifier><language>eng</language><ispartof>European heart journal, 2021-10, Vol.42 (Supplement_1)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Eliaz, R</creatorcontrib><creatorcontrib>Mengesha, B</creatorcontrib><creatorcontrib>Ovdat, T</creatorcontrib><creatorcontrib>Iakobishvili, Z</creatorcontrib><creatorcontrib>Hasdai, D</creatorcontrib><creatorcontrib>Kheifets, M</creatorcontrib><creatorcontrib>Klempfner, R</creatorcontrib><creatorcontrib>Beigel, R</creatorcontrib><creatorcontrib>Kalmanovich, E</creatorcontrib><creatorcontrib>Alcalai, R</creatorcontrib><creatorcontrib>Levi, A</creatorcontrib><creatorcontrib>Acute Coronary Syndrome Israeli Survey (ACSIS)</creatorcontrib><title>Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)</title><title>European heart journal</title><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKAzEYhYMoWKuvIFnWxbS5TSZZlsFLoWCxCroaksw_nZR2piQzhT6Gb2yLxZ2rsziHj8OH0D0lY0o0n0AfajChW0-gNjZjYkwFFRdoQFPGEi1FeokGhOo0kVJ9XqObGNeEECWpHKDvN9hDiN5uAC_YF2XYN7W3vmsDPhV9xD6E_ze-wdN8iXem89B0EfdNCWHV-maFF_kMj7oasHF9B9i1oW1MOOB4aMrQbgH7GAxsPI592MMBj46g2fLhFl1VZhPh7pxD9PH0-J6_JPPX51k-nSeO8kwkrALDXVrZsnQsE5pmruTKZSZLS2Gc1UqnOrPSMsukAMqkIlxpygVxSoHmQyR_uS60MQaoil3w2-PBgpLiJLb4E1ucxRYnsfwH-GZx6w</recordid><startdate>20211012</startdate><enddate>20211012</enddate><creator>Eliaz, R</creator><creator>Mengesha, B</creator><creator>Ovdat, T</creator><creator>Iakobishvili, Z</creator><creator>Hasdai, D</creator><creator>Kheifets, M</creator><creator>Klempfner, R</creator><creator>Beigel, R</creator><creator>Kalmanovich, E</creator><creator>Alcalai, R</creator><creator>Levi, A</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20211012</creationdate><title>Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)</title><author>Eliaz, R ; Mengesha, B ; Ovdat, T ; Iakobishvili, Z ; Hasdai, D ; Kheifets, M ; Klempfner, R ; Beigel, R ; Kalmanovich, E ; Alcalai, R ; Levi, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1374-2fea3c5fbddc274917cd38c7a75d4acb989597b6b2b264e126803891340c88e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eliaz, R</creatorcontrib><creatorcontrib>Mengesha, B</creatorcontrib><creatorcontrib>Ovdat, T</creatorcontrib><creatorcontrib>Iakobishvili, Z</creatorcontrib><creatorcontrib>Hasdai, D</creatorcontrib><creatorcontrib>Kheifets, M</creatorcontrib><creatorcontrib>Klempfner, R</creatorcontrib><creatorcontrib>Beigel, R</creatorcontrib><creatorcontrib>Kalmanovich, E</creatorcontrib><creatorcontrib>Alcalai, R</creatorcontrib><creatorcontrib>Levi, A</creatorcontrib><creatorcontrib>Acute Coronary Syndrome Israeli Survey (ACSIS)</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eliaz, R</au><au>Mengesha, B</au><au>Ovdat, T</au><au>Iakobishvili, Z</au><au>Hasdai, D</au><au>Kheifets, M</au><au>Klempfner, R</au><au>Beigel, R</au><au>Kalmanovich, E</au><au>Alcalai, R</au><au>Levi, A</au><aucorp>Acute Coronary Syndrome Israeli Survey (ACSIS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)</atitle><jtitle>European heart journal</jtitle><date>2021-10-12</date><risdate>2021</risdate><volume>42</volume><issue>Supplement_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><doi>10.1093/eurheartj/ehab724.1414</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2021-10, Vol.42 (Supplement_1)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehab724_1414
source Oxford Journals Online
title Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A00%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reversible%20P2Y12%20inhibitor%20versus%20irreversible%20P2Y12%20inhibitor%20in%20ACS%20patients%20undergoing%20PCI%20(the%20acute%20coronary%20syndrome%20israeli%20survey%20(ACSIS)&rft.jtitle=European%20heart%20journal&rft.au=Eliaz,%20R&rft.aucorp=Acute%20Coronary%20Syndrome%20Israeli%20Survey%20(ACSIS)&rft.date=2021-10-12&rft.volume=42&rft.issue=Supplement_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehab724.1414&rft_dat=%3Ccrossref%3E10_1093_eurheartj_ehab724_1414%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1374-2fea3c5fbddc274917cd38c7a75d4acb989597b6b2b264e126803891340c88e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true